VSIG4 Restricts Hepatocellular Carcinoma Control by Suppressing Tumor-Specific CD8+ T-cell Immunity in the Tumor Microenvironment.

Saved in:
Bibliographic Details
Title: VSIG4 Restricts Hepatocellular Carcinoma Control by Suppressing Tumor-Specific CD8+ T-cell Immunity in the Tumor Microenvironment.
Authors: Guo J; Department of Cancer Immunology, Genentech, South San Francisco, California., Bhela S; Department of Cancer Immunology, Genentech, South San Francisco, California., Sharma M; Department of Research Biology, Genentech, South San Francisco, California., Protti G; Department of Computational Biology and Translation, Genentech, South San Francisco, California., Luoh SM; Department of Cancer Immunology, Genentech, South San Francisco, California., Wang S; Department of Cancer Immunology, Genentech, South San Francisco, California., Firmino NS; Department of Cancer Immunology, Genentech, South San Francisco, California., Dasoveanu DC; Department of Cancer Immunology, Genentech, South San Francisco, California., Chan C; Department of Research Pathology, Genentech, South San Francisco, California., Ibarra-Lopez V; Department of Research Pathology, Genentech, South San Francisco, California., Foo C; Department of Research Pathology, Genentech, South San Francisco, California., Jesudason R; Department of Research Pathology, Genentech, South San Francisco, California., Rost S; Department of Research Pathology, Genentech, South San Francisco, California., Scholl T; Department of Research Support Facility, Genentech, South San Francisco, California., Ziai J; Department of Research Pathology, Genentech, South San Francisco, California., Comps-Agrar L; Department of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California., Wang Y; Department of Translational Medicine Oncology, Genentech, South San Francisco, California., Müller S; Department of Computational Biology and Translation, Genentech, South San Francisco, California., Shaw AS; Department of Research Biology, Genentech, South San Francisco, California., Li J; Department of Biochemical and Cellular Pharmacology, Genentech, South San Francisco, California., Turley SJ; Department of Immunology and Regenerative Medicine, Genentech, South San Francisco, California., Fu W; Department of Cancer Immunology, Genentech, South San Francisco, California.
Source: Cancer immunology research [Cancer Immunol Res] 2026 May 04; Vol. 14 (5), pp. 718-732.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2326-6074
DOI:10.1158/2326-6066.CIR-25-0836